Navratan Bio Science Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 12 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.35 M
as on 24-10-2024
- Revenue 113.47%
(FY 2023)
- Profit -19.60%
(FY 2023)
- Ebitda 17.34%
(FY 2023)
- Net Worth -39.43%
(FY 2023)
- Total Assets 13.98%
(FY 2023)
About Navratan Bio Science
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.35 M.
Rishab Golecha and Prakshali Jain serve as directors at the Company.
- CIN/LLPIN
U36101DL2012PTC244018
- Company No.
244018
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Oct 2012
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Navratan Bio Science Private Limited offer?
Navratan Bio Science Private Limited offers a wide range of products and services, including Organic Fertilizers and Manure, Bio Potash, Phosphate Rich Organic Manure (PROM), Fertilizer, Plant Growth Regulators, Bio Fertilizers, Azospirillum Biofertilizer, Bio Insecticides, Seaweed Extract Fertilizers, Nitrogen Fertilizers.
Who are the key members and board of directors at Navratan Bio Science?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rishab Golecha  | Director | 11-Jul-2019 | Current |
| Prakshali Jain | Director | 11-Jul-2019 | Current |
Financial Performance of Navratan Bio Science.
Navratan Bio Science Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 113.47% increase. The company also saw a substantial fall in profitability, with a 19.6% decrease in profit. The company's net worth observed a substantial decline by a decrease of 39.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Navratan Bio Science?
In 2023, Navratan Bio Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 12 Jun 2023 | ₹1.35 M | Open |
How Many Employees Work at Navratan Bio Science?
Unlock and access historical data on people associated with Navratan Bio Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Navratan Bio Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Navratan Bio Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
